Combined Endophthalmitis and Orbital Cellulitis in Patients with Corona Virus Disease (COVID-19)

Overview

Journal J Ophthalmic Inflamm Infect

Publisher Springer

Specialty Ophthalmology

Date 2021 Sep 15

PMID 34523045

Citations 3

Authors

Mohamed Farouk Sayed Othman Abdelkader

Ahmed Mohamed Kamal Elshafei

Mahmoud Mamdouh Nassar

Mostafa A Abu Elela

Raafat Mohyeldeen Abdelrahman Abdallah

Affiliations

Soon will be listed here.

Abstract

Purpose: To document the presentation of unilateral combined endophthalmitis and orbital cellulitis in patients with COVID-19 infection and study their prognosis.

Patients And Methods: This interventional case series study included 9 patients referred to the Ophthalmology Department, Minia University Hospital with unilateral combined endophthalmitis and orbital cellulitis between April 2020 and March 2021. In addition to the COVID-19 work-up, all patients were subjected to full ophthalmological evaluation and managed according to their ophthalmic and systemic disease.

Results: The patients were 5 females and 4 males. They had clinical, laboratory and imaging findings that confirmed COVID-19 infection. All patients had unilateral endophthalmitis with orbital cellulitis and profound visual loss in the affected eye. Three patients died due to respiratory failure, while 6 patients recovered systemically. The survived patients developed atrophia bulbi in 4 patients and in 2 patients, the globe retained normal size but with complete visual loss.

Conclusion: Combined endophthalmitis and orbital cellulitis can be one of the early presentations of patients with COVID-19 infection with poor visual prognosis.

Trial Registration: Clinical registration: clinicaltrials.gov identifier: NCT04456556 .

Citing Articles

Ocular manifestations of COVID-19: A systematic review of current evidence.

SeyedAlinaghi S, Mehraeen E, Afzalian A, Dashti M, Ghasemzadeh A, Pashaei A Prev Med Rep. 2024; 38:102608.

PMID: 38375172 PMC: 10874879. DOI: 10.1016/j.pmedr.2024.102608.

Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report.

Boontantrapiwat S, Rojanaporn D, Chokthaweesak W, Kitnarong N Am J Ophthalmol Case Rep. 2022; 28:101707.

PMID: 36128343 PMC: 9479422. DOI: 10.1016/j.ajoc.2022.101707.

How Does SARS-CoV-2 Affect Our Eyes-What Have We Learnt So Far about the Ophthalmic Manifestations of COVID-19?.

Baj J, Forma A, Teresinska B, Tyczynska M, Zembala J, Januszewski J J Clin Med. 2022; 11(12).

PMID: 35743449 PMC: 9225256. DOI: 10.3390/jcm11123379.

References

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Turbin R, Wawrzusin P, Sakla N, Traba C, Wong K, Mirani N . Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19. Orbit. 2020; 39(4):305-310. DOI: 10.1080/01676830.2020.1768560. View

Smitha K, Deshmukh A, Manjandavida F, Babu K . Pediatric viral orbital cellulites secondary to H1N1 infection: A case report. Indian J Ophthalmol. 2019; 67(7):1234-1235. PMC: 6611327. DOI: 10.4103/ijo.IJO_1549_18. View

Daruich A, Martin D, Bremond-Gignac D . Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context. J Fr Ophtalmol. 2020; 43(5):389-391. PMC: 7164841. DOI: 10.1016/j.jfo.2020.04.002. View

Yoshida A, Obata H, Kawashima H . Cytomegalovirus Uveitis with Hypopyon Mimicking Bacterial Endophthalmitis. Case Rep Ophthalmol Med. 2015; 2015:489813. PMC: 4442280. DOI: 10.1155/2015/489813. View

Chin M, Hooper L, Hooks J, Detrick B . Identification of α-fodrin as an autoantigen in experimental coronavirus retinopathy (ECOR). J Neuroimmunol. 2014; 272(1-2):42-50. PMC: 7112846. DOI: 10.1016/j.jneuroim.2014.05.002. View

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

Elshafei A, Sayed M, Abdallah R . Clinical profile and outcomes of management of orbital cellulitis in Upper Egypt. J Ophthalmic Inflamm Infect. 2017; 7(1):8. PMC: 5342996. DOI: 10.1186/s12348-017-0126-3. View

DeBiasi R, Song X, Delaney M, Bell M, Smith K, Pershad J . Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region. J Pediatr. 2020; 223:199-203.e1. PMC: 7217783. DOI: 10.1016/j.jpeds.2020.05.007. View

10.

Connell P, ONeill E, Fabinyi D, Islam F, Buttery R, McCombe M . Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye (Lond). 2010; 25(1):66-72. PMC: 3144637. DOI: 10.1038/eye.2010.145. View

11.

Vilela R, Vilela L, Vilela P, Vilela R, Motta R, Possa A . Etiological agents of fungal endophthalmitis: diagnosis and management. Int Ophthalmol. 2013; 34(3):707-21. DOI: 10.1007/s10792-013-9854-z. View

12.

Greenwald M, Wohl L, Sell C . Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol. 1986; 31(2):81-101. DOI: 10.1016/0039-6257(86)90076-7. View

13.

Napoli P, Nioi M, dAloja E, Fossarello M . The Ocular Surface and the Coronavirus Disease 2019: Does a Dual 'Ocular Route' Exist?. J Clin Med. 2020; 9(5). PMC: 7287662. DOI: 10.3390/jcm9051269. View

14.

Jackson T, Eykyn S, Graham E, Stanford M . Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003; 48(4):403-23. DOI: 10.1016/s0039-6257(03)00054-7. View

15.

Borne M, Shields J, Shields C, De Porter P, Ehya H . Bilateral viral endophthalmitis as the presenting sign of severe combined immunodeficiency. Arch Ophthalmol. 1994; 112(10):1280-1. DOI: 10.1001/archopht.1994.01090220030013. View

16.

Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P . Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395(10237):1607-1608. PMC: 7204765. DOI: 10.1016/S0140-6736(20)31094-1. View

17.

Senanayake P, Drazba J, Shadrach K, Milsted A, Rungger-Brandle E, Nishiyama K . Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci. 2007; 48(7):3301-11. DOI: 10.1167/iovs.06-1024. View

18.

Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M . Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020; 104(6):748-751. PMC: 7211077. DOI: 10.1136/bjophthalmol-2020-316304. View

19.

Wagner J, Danser A, Derkx F, de Jong T, Paul M, Mullins J . Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol. 1996; 80(2):159-63. PMC: 505409. DOI: 10.1136/bjo.80.2.159. View

20.

Dockery D, Rowe S, Murphy M, Krzystolik M . The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention. J Emerg Med. 2020; 59(1):137-140. PMC: 7205711. DOI: 10.1016/j.jemermed.2020.04.060. View